Newsletter - April 30, 2020
Are There Too Many Clinical Trials for COVID-19 Therapies?
There are more than 1000 clinical trials currently ongoing to evaluate various aspects of COVID-19, creating a pressure for recruiting patients and raising questions about the negative effects of the over-competition. But that may not be a fair question to ask. With more than 3.1 million confirmed infections and 228,000 deaths...Read More
The Negative Outcomes of Pre-EUA: Lessons from COVID Antibody Tests
The Emergency Use Authorization (EUA) is a very important tool for fighting special circumstances but the COVID-19 emergency has exposed that these can be exploited financially by bad players. Since the declaration of the emergency, FDA has relaxed several rules governing personal protection equipment (PPEs) and...Read More
Are There Too Many Clinical Trials for COVID-19 Therapies?
There are more than 1000 clinical trials currently ongoing to evaluate various aspects of COVID-19, creating a pressure for recruiting patients and raising questions about the negative effects of the over-competition. But that may not be a fair question to ask. With more than 3.1 million confirmed infections and 228,000 deaths...Read More
The Negative Outcomes of Pre-EUA: Lessons from COVID Antibody Tests
The Emergency Use Authorization (EUA) is a very important tool for fighting special circumstances but the COVID-19 emergency has exposed that these can be exploited financially by bad players. Since the declaration of the emergency, FDA has relaxed several rules governing personal protection equipment (PPEs) and...Read More
